Elevance Health, Inc. (NYSE:ELV) Targets High Growth Amid Healthcare Innovations

Ann Hynes from Mizuho Securities sets a price target of $350 for Elevance Health, Inc. (NYSE:ELV), indicating a potential upside of approximately 23.81%.The company showcased its strategies at the Barclays 28th Annual Global Healthcare Conference, reflecting confidence in its market position and future growth.Elevance Health's stock has experienced volatility, with a yearly high of $458.75 and a low of $273.71, showcasing the dynamic nature of the healthcare sector.Elevance Health, Inc. (NYSE:ELV) is a prom ...